VNDA Insider Trading – Vanda Pharmaceuticals Inc
Vanda is making a lot of news lately. Their drug for treating schizophrenia was approved by the FDA. This moved the stock from around $1.20 to around $8.50 per share in a single day. At the end of the day on 5/7/09 the stock was at 7.84.
Some other interesting things occured with VNDA on the prior day. INTERESTING! 4 executives at the company received option grants on shares. In fact, it appears (according to the Form 4 filings for VNDA at the SEC) those shares are the only shares owned by the Vanda executives.
This smells a little funny. Awarded options on 5/6 and MAJOR news on 5/7?
Call me crazy, tell me my timing is wrong, or that my facts aren’t correct, but this smells a little odd. Insider info? Nah. Legal? I don’t know. Probably.
| Transaction & Date |
Reported Date |
Company | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2009-05-06 Option Award |
2009-05-07 6:31 pm |
Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos (Chief Executive Officer Director) |
75,000 | $0 | 75,000 (Direct) |
View |
| 2009-05-06 Option Award |
2009-05-07 6:28 pm |
Vanda Pharmaceuticals Inc. | Irish Stephanie Rast (Sr. VP, Acting CFO/Treasurer) |
20,000 | $0 | 20,000 (Direct) |
View |
| 2009-05-06 Option Award |
2009-05-07 6:26 pm |
Vanda Pharmaceuticals Inc. | Feeney John Joseph (Acting Chief Medical Officer) |
20,000 | $0 | 20,000 (Direct) |
View |
| 2009-05-06 Option Award |
2009-05-07 6:25 pm |
Vanda Pharmaceuticals Inc. | Clark William D (Sr. VP, Chief Business Officer) |
25,000 | $0 | 25,000 (Direct) |
View |
via VNDA Insider Trading – Vanda Pharmaceuticals Inc. – Form 4 SEC Filings.
Related articles:
